startup

TolerogenixX

TolerogenixX hat eine patentierte Technologie, mit der man unerwünschte Immunreaktionen im Körper unterdrücken kann.
  • Biowissenschaften & Gesundheitspflege
  • Startup-Phase
  • Herstellung
  • B2B
  • 2018
  • 1-10 Mitarbeiter
  • Existiert
  • Heidelberg, DE
  • tolerogenixx.com
  • TolerogenixX GmbH

Über die Firma

TolerogenixX has an innovative cell technology that can be used to suppress unwanted immune responses in the body. This novel cell therapy will revolutionize the treatment of transplant recipients and numerous autoimmune diseases.

The unique feature of the TolerogenixX method is the simple modification of white blood cells by use of the TolerogenixX therapy kit. Once infused, these modified cells suppress unwanted immune responses in the patient´s body. The first patients have already been successfully treated in a phase-I clinical study in kidney transplantation.

Due to the promising results from the phase I study, there are already preparations for the TOL-2 phase II study.

TolerogenixX funding

TolerogenixX Funding

Team-Mitglieder

Matthias Schaier

FYI: English edition available

Hello my friend, have you been stranded on the German edition of Startbase? At least your browser tells us, that you do not speak German - so maybe you would like to switch to the English edition instead?

Go to English edition

FYI: Deutsche Edition verfügbar

Hallo mein Freund, du befindest dich auf der Englischen Edition der Startbase und laut deinem Browser sprichst du eigentlich auch Deutsch. Magst du die Sprache wechseln?

Deutsche Edition öffnen